Wilson Tuah

Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial

Willemien A. Nienhuis, Ymkje Stienstra, William A. Thompson et al. · The Lancet · 2010 · 278 citations

Pharmacy, Infectious Diseases, Microbiology +12

Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial

Richard Odame Phillips, J. Robert, Kabiru Mohamed Abass et al. · The Lancet · 2020 · 110 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +10

Paradoxical Responses After Start of Antimicrobial Treatment in Mycobacterium ulcerans Infection

Willemien A. Nienhuis, Ymkje Stienstra, Karibu M. Abass et al. · Clinical Infectious Diseases · 2011 · 102 citations · Full text

Veterinary Medicine, Dermatology, Infectious Diseases +15

Long Term Streptomycin Toxicity in the Treatment of Buruli Ulcer: Follow-up of Participants in the BURULICO Drug Trial

Sandor Klis, Ymkje Stienstra, Richard Odame Phillips et al. · PLoS neglected tropical diseases · 2014 · 70 citations · Full text

Pharmacy, Pharmacotherapy, Toxicology +12

Clinical and Bacteriological Efficacy of Rifampin-Streptomycin Combination for Two Weeks followed by Rifampin and Clarithromycin for Six Weeks for Treatment of Mycobacterium ulcerans Disease

Richard Odame Phillips, Fred Stephen Sarfo, Mohammed K. Abass et al. · Antimicrobial Agents and Chemotherapy · 2013 · 65 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17